MDM2 and thyroid cancer: Conversely, Malaguarnera et al. suggested that in thyroid cancer cells, TAp73α promotes p53 protein expression by inhibiting MDM2-mediated p53 degradation, proposing a thyroid-specific dual function for this TSG [134].